Jessica Konen

Dr. Jessica Konen

orcid

Biography

For the past 14 years, I have studied various aspects of lung cancer biology, including invasion and metastasis, drug resistance, and the immune response. I received my Ph.D. in Cancer Biology from Emory University, and I studied the dynamic interplay between invasive subpopulations in lung cancer cells that promoted successful metastasis. From there, I completed my post-doctoral fellowship at MD Anderson. While I remained in the field of lung cancer, my post-doctoral research focused on drug resistance mechanisms, both to targeted therapies and to immune checkpoint inhibitors (ICI), to generate pre-clinical evidence for new combinatorial treatment strategies. My independent lab further dissects ICI therapy resistance mechanisms particularly in non-small cell lung cancer. We aim to study dynamic tumor:immune cell interactions to reveal targetable survival dependencies, thus preventing resistance. In particular, we examine the accumulation of certain bioactive metabolites within the tumor microenvironment that influence anti-tumor immunity.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

Senior Scientist or Principal Investigator

Emory University, Atlanta, USA

01 Mar 2022 - present

Post Doctoral Researcher

The University of Texas MD Anderson Cancer Center, Houston, USA

01 Jan 2017 - 01 Mar 2022

Graduate Student or Post Graduate

Emory University, Atlanta, USA

01 Aug 2011 - 01 Dec 2016